Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Yan Ming, Chief Technology Officer. Officer active across 1 company, notably Cytek Biosciences, Inc.. Aggregated, 40 reports have been published. Split: 0 buy · 22 sells. Total volume traded: €3.5m. History available since 10 February 2022. The latest transaction was disclosed on 19 April 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
897 shares@ US$13.530.3% of flowCommon StockSEC:0001209191-23-008517:0
25 of 40 declarations
About Yan Ming
Yan Ming is the Chief Technology Officer of Cytek Biosciences, Inc. In this role, he oversees technological development and innovation within the company. His technical expertise is essential to ensure that Cytek Biosciences, Inc. remains at the forefront of innovation in the life sciences sector.